These cells release a spectrum of immunosuppressive cytokines, including transforming growth factor-beta (TGF-β) and interleukin-10 (IL-10), which further diminish the activity of effector T cells and promote tumor tolerance (Fig. 1) [22]. This evidence concerns the gene TGFB1 and neoplasm.